Sartorius Stock
Sartorius AG
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- Germany
- CEO
- Michael Grosse
- Employees
- 14,042
- Market cap
- €18 B
- IPO
- 06/04/1999
Sartorius AG, headquartered in Göttingen, Germany, is a global supplier of advanced bioprocess solutions, laboratory products, and associated services. Founded in 1870, the company operates within the Healthcare sector and the Medical - Instruments & Supplies industry. Its diverse portfolio encompasses several…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Sartorius stock: price history
1D
-1.7%
1W
+0.5%
1M
+5.7%
6M
+9.2%
YTD
+7.6%
1Y
+10.1%
2Y
+14.3%
5Y
-64.6%
10Y
+165.8%
Next earnings date
Next earnings date
22/10/2026 (in 5 days)
Volatility around earnings
~35% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 14/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Sartorius
Analyst assessment of Sartorius
0
STRONG BUY
0
BUY
2
HOLD
0
SELL
0
STRONG SELL
2
TOTAL · Hold
As of: 10/11/2020
Sartorius stock metrics
P/E
92.23
P/B
6.38
EV/EBITDA
18.9
RETURN ON EQUITY
1.5%
NET MARGIN
4.5%
DEBT/EQUITY
1.44
DIVIDEND YIELD
0.3%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
4.4%
FLOAT SHARES
3,012,198
AVG. DAILY VOLUME (30D)
3,446
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Sartorius stock
What does Sartorius do?
Sartorius AG is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in Germany.
The CEO is Michael Grosse, the company employs around 14,042 people.
The IPO was on 06/04/1999; the stock trades on XETRA under the ticker SRT.DE.
What do analysts say about Sartorius stock?
2 analysts rate the stock, the consensus is Hold (as of 10/11/2020).
This is an external assessment, not a statement by Market Jury.
When does Sartorius report next?
The next earnings date is 22/10/2026.
Around past earnings, price swings were roughly 35% stronger than usual.
Does Sartorius pay a dividend?
Yes. The last dividend was €0.73 per share, ex-date 27/03/2026, paid on 31/03/2026.
The dividend yield is 0.3% (as of 30/06/2026).
Which stocks are comparable to Sartorius?
Comparable stocks include Sartorius, Anbio Biotechnology, Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum and Baxter International.
How can I get Sartorius stock analyzed?
Clicking "Analyze stock" lets five strategies assess Sartorius against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.